A (p)ppGpp-Null Mutant of Haemophilus ducreyi Is Partially Attenuated in Humans Due to Multiple Conflicting Phenotypes by Holley, Concerta et al.
A (p)ppGpp-Null Mutant of Haemophilus ducreyi Is Partially
Attenuated in Humans Due to Multiple Conflicting Phenotypes
Concerta Holley,a Dharanesh Gangaiah,a Wei Li,a Kate R. Fortney,a Diane M. Janowicz,c Sheila Ellinger,c Beth Zwickl,c Barry P. Katz,d,f
Stanley M. Spinolaa,b,c,e
Departments of Microbiology and Immunology,a Pathology and Laboratory Medicine,b Medicine,c Biostatistics,d and Center for Immunobiology,e Indiana University
School of Medicine, Indianapolis, Indiana, USA; Department of Biostatistics, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USAf
(p)ppGpp responds to nutrient limitation through a global change in gene regulation patterns to increase survival. The stringent
response has been implicated in the virulence of several pathogenic bacterial species.Haemophilus ducreyi, the causative agent
of chancroid, has homologs of both relA and spoT, which primarily synthesize and hydrolyze (p)ppGpp in Escherichia coli. We
constructed relA and relA spoT deletion mutants to assess the contribution of (p)ppGpp toH. ducreyi pathogenesis. Both the
relA single mutant and the relA spoT double mutant failed to synthesize (p)ppGpp, suggesting that relA is the primary synthe-
tase of (p)ppGpp inH. ducreyi. Compared to the parent strain, the double mutant was partially attenuated for pustule formation
in human volunteers. The double mutant had several phenotypes that favored attenuation, including increased sensitivity to
oxidative stress. The increased sensitivity to oxidative stress could be complemented in trans. However, the double mutant also
exhibited phenotypes that favored virulence. When grown to the mid-log phase, the double mutant was significantly more resis-
tant than its parent to being taken up by humanmacrophages and exhibited increased transcription of lspB, which is involved in
resistance to phagocytosis. Additionally, compared to the parent, the double mutant also exhibited prolonged survival in the
stationary phase. In E. coli, overexpression of DksA compensates for the loss of (p)ppGpp; theH. ducreyi double mutant ex-
pressed higher transcript levels of dksA than the parent strain. These data suggest that the partial attenuation of the double mu-
tant is likely the net result of multiple conflicting phenotypes.
Haemophilus ducreyi is the causative agent of chancroid, a sex-ually transmitted genital ulcer disease that is endemic in the
developing world (1). Like other genital ulcer diseases, chancroid
facilitates both the transmission and acquisition of HIV-1 (1).
Due to a short duration of infectivity, H. ducreyi can be main-
tained only in populations with high sex partner change rates,
such as commercial sex workers. As a result of syndromic man-
agement of genital ulcers, chancroid prevalence has declined in
many areas of endemicity and the overall global prevalence of
chancroid is now undefined (2). However, reports of chancroid
persist from Africa and Asia, implying that these regions have
reservoirs of infected sex workers (3–8).
In the South Pacific, H. ducreyi also causes a non-sexually
transmitted skin ulceration syndrome that clinically resembles
yaws due to Treponema pallidum subspecies pertenue (9–13). In a
recent prospective cohort study conducted in an area of yaws en-
demicity of PapuaNewGuinea, the prevalence of this syndrome is
3.2 cases per 100 persons;H. ducreyiDNA is detected in 60%of the
ulcers and Treponema pallidumDNA is detected in 34%, suggest-
ing that H. ducreyi is the major cause of this syndrome (9).
AlthoughH. ducreyi is thought to be universally susceptible to
third-generation cephalosporins, macrolides, and quinolones, re-
ports of resistance to or treatment failures with these agents oc-
curred in the early 1990s (14–16). Due to syndromic manage-
ment, no new data on antimicrobial susceptibility have been
available for nearly 20 years. Given the new epidemiological data
and lack of information regarding its antimicrobial susceptibility,
understanding the pathogenesis of H. ducreyi remains important
for the development of alternative disease control strategies.
In order to study H. ducreyi pathogenesis, we developed a hu-
man inoculation model in which healthy adult volunteers are in-
fected on the upper arm with H. ducreyi (17). The model mimics
both the papular and pustular stages of natural infection. Impor-
tantly, in both natural and experimental infection, H. ducreyi is
found within abscesses surrounded by macrophages and poly-
morphonuclear leukocytes (18). Within these abscesses, H. du-
creyi encounters a variety of stresses, including antimicrobial pep-
tides, an anaerobic environment, and reactive oxygen species (19).
When faced with stress, bacteria alter gene expression through
the use of alternative sigma factors, two-component systems, and
second messengers. Although these systems overlap, each system
is optimized to respond to a particular stressor. The genome ofH.
ducreyi contains only two alternative sigma factors (RpoE and
RpoH) and lacks RpoS, which usually plays a major role in stress
tolerance and stationary-phase survival. Additionally, H. ducreyi
has only one intact two-component system, CpxRA, which is dis-
pensable for human infection (20).H. ducreyi contains homologs
of relA and spoT, key components of the stringent response sys-
tem; relA transcripts are upregulated during human infection
(21).
The stringent response is usually induced by nutrient-lim-
iting conditions. The response allows a global alteration in gene
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expression through guanosine pentaphosphate (pppGpp) and
guanosine tetraphosphate (ppGpp), collectively referred to
here as (p)ppGpp. In response to amino acid limitation, RelA
catalyzes the synthesis of (p)ppGpp. (p)ppGpp directly interacts
with the -subunit of the RNA polymerase, altering its activity
(22, 23). Through its interaction with RNA polymerase,
(p)ppGpp upregulates genes that are necessary for survival and
increases use of alternative sigma factors. Simultaneously, genes
that are not crucial for survival, such as those involved in protein
synthesis and growth, are downregulated. Upon removal of the
stressor, SpoT degrades (p)ppGpp to quench the response. Under
certain conditions such as iron limitation, SpoT’s limited
(p)ppGpp synthetic capabilities also serve to initiate the stringent
response (24). A mutant with deletions in both relA and spoT is
generally incapable of initiating a stringent response; such strains
are called (p)ppGpp null [(p)ppGpp0] mutants.
The stringent response is linked to the virulence of several patho-
genic bacterial species.Legionella pneumophila (p)ppGpp0mutants
are defective in transmission between macrophages, a critical
component of Legionella pathogenesis (25). (p)ppGpp0mutants
of Yersinia pestis, Salmonella enterica serovar Typhimurium, and
Borrelia burgdorferi are completely avirulent in animal models of
infection (26–28). (p)ppGpp0 mutants of Staphylococcus aureus,
Pseudomonas aeruginosa,Mycobacterium tuberculosis, and Entero-
coccus faecalis are less virulent than their wild-type parents in their
respective animal models of infection (29–32). However, the role
of the stringent response in a bacterial pathogen has never been
directly studied in humans.
To investigate the role of the stringent response in H. ducreyi
pathogenesis, we constructed H. ducreyi relA and relAspoT
mutants, the latter of which should be (p)ppGpp0. We compared
the virulence of the double mutant to that of the parent strain in
human inoculation experiments.We also compared bothmutants
to the parent strain in phagocytosis, serum killing, and oxidative
stress tolerance assays. We found that the (p)ppGpp mutants had
increased sensitivity to oxidative stress. Importantly, relA and
spoT contributed to disease progression in human volunteers.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions.The bacterial strains
andplasmids used in this study are listed inTable 1.H. ducreyi strainswere
grown on chocolate agar plates supplemented with 1% IsoVitalex at 33°C
with 5% CO2 or in gonococcal (GC) broth supplemented with 5% fetal
bovine serum (HyClone), 1% IsoVitalex, and 50 g/ml hemin (Aldrich
Chemical Co.) at 33°C. H. ducreyi 35000HP was grown to the mid-log
phase (optical density at 660 nm [OD660]  0.2), transition phase
(OD660  0.3 to 0.35), and stationary phase (OD660  0.45 to 0.55);
mutant strains were harvested when the OD660 of 35000HP was in the
appropriate range for each phase of growth. Escherichia coli strains were
grown in Luria-Bertanimedia at 37°C,with the exception of strainDY380,
whichwasmaintained in low-salt broth or agar at 32°C and grown at 42°C
for induction of the lambda red recombinase. When necessary, media
were supplemented with kanamycin (20 g/ml for H. ducreyi; 50 g/ml
for E. coli) or spectinomycin (200 g/ml for H. ducreyi; 50 g/ml for E.
coli). For H. ducreyi strains containing a pACYC177 backbone, media
were supplemented with 30 g/ml kanamycin.
Reverse transcriptase PCR (RT-PCR) and quantitative RT-PCR
(qRT-PCR). Total RNA was extracted using TRIzol reagent (Invitrogen)
according to the manufacturer’s protocol. The RNA was treated with
Turbo DNA-free DNase (Ambion) and purified using an RNeasy minikit
(Qiagen). The integrity and concentration of the RNA were determined
using an Agilent Bioanalyzer (Agilent Technologies) and a NanoDrop
ND2000 (Thermo Scientific), respectively. cDNA was synthesized from
total RNA using a Super Smart cDNA synthesis kit (Clontech).
RT-PCR and qRT-PCR were performed using a QuantiTect SYBR
green RT-PCR kit (Qiagen) in an ABI Prism 7000 sequence detector (Ap-
plied Biosystems). All primer pairs (see Table S1 in the supplemental
material) had greater than 95% amplification efficiency. Relative expres-
TABLE 1 Bacterial strains and plasmids used in this study
Strain(s) or plasmid Descriptiona Source or reference
E. coli strains
DH5, Top10, and HB101 Strains used for general cloning procedures Invitrogen
DY380 DH10B derivative containing a defective  prophage in which the red, bet, and gam genes are
controlled by the temp-sensitive cI857 repressor
64
H. ducreyi strains
35000HP Human-passaged variant of strain 35000 65
35000HPrelA Unmarked, in-frame relA deletion mutant This study
35000HPrelAspoT Unmarked, in-frame relA and spoT double-deletion mutant This study
FX517 35000HPdsrA::cat insertion mutant 44
Plasmids
pCH1 pCR-XL-TOPO containing the relA-coding region along with 0.5-kb flanking regions This study
PCH11 pCR-XL-TOPO containing the spoT-coding region along with 0.5-kb flanking regions This study
pRSM2832 Plasmid containing spectinomycin resistance cassette flanked by the FRT sites 66
pRSM2072 H. ducreyi suicide vector 33
pRSM2975 Plasmid containing the origin of replication and kanamycin resistance gene from pLS88, FLP
recombinase gene from pFT-A, and a point mutation conferring a temp-sensitive phenotype
in H. ducreyi
42
pACYC177 Cloning vector, Kanr Ampr for complementation New England Biolabs
pACYC184 Cloning vector, Cmr Tetr New England Biolabs
pCH30 pACYC177 containing the cat promoter from pACYC184 followed by the 35000HP spoT gene in
front of the 35000HP relA gene
This study
a Kanr, kanamycin resistance; Ampr, ampicillin resistance; Cmr and cat, chloramphenicol resistance and gene; Tetr, tetracycline resistance.
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sionwas calculated as [(Etarget
CTtarget)/(Ereferencce
CTreference)], where E is
the amplification efficiency, (101/slope), and CT is the change in the
cycle threshold. For normalization of expression levels of target genes,
dnaE was amplified using primer pair P1 and P2.
Characterization of the relA and spoT genes. The Basic Local Align-
ment Search Tool (BLAST) was used to identify putative homologues of
relA and spoT inH. ducreyi (GenBank accession no. AE017143). RT-PCR
was conducted to determine if relA or spoT was in an operon with sur-
rounding genes. The relA-to-dxr intergenic region was amplified using
primers P3 and P4. The intergenic regions around spoT were amplified
using primers P5 and P6 for recG to rpoZ, P7 and P8 for rpoZ to spoT, and
P9 and P10 for spoT to menB.
Construction and complementation of unmarked, in-frame relA
single-deletion and relA spoT double-deletion mutants. An unmarked,
in-frame relA deletion mutant was constructed using the  red and FLP
recombinase method described previously (33, 34). To construct a relA
deletion mutant, primers P11 and P12 were used to amplify the spectino-
mycin (spec) resistance cassette flanked by flippase recognition target
(FRT) sites frompRSM2832. P11 included 47 bp upstream of relA and the
ATG start codon. P12 included 21 bp at the 3= end of relA, the stop codon,
and 29 bp downstream of relA.
The coding region of relA, along with a 0.5-kb flanking region on
either side of the gene, was amplified using primers P13 and P14. The
product was cloned into pCR-XL-TOPO. The construct, designated
pCH1, was then electroporated into E. coliDY380, which contains a tem-
perature-sensitive  red recombinase. The product from primers P11 and
P12 was electroporated into the DY380 strain generated as described
above. Following induction of the recombinase, the relA gene was re-
placed with the spec cassette with the exception of the start codon and the
last 21 bp of the relA gene. The spec cassette containing the flanking re-
gions was digested with SpeI and cloned into the pRSM2072 suicide vec-
tor. This construct was electroporated into strain 35000HP. Chocolate
agar containing spectinomycin and 5-bromo-4-chloro-3-indolyl--D-ga-
lactopyranoside was used to detect clones in which allelic exchange had
occurred. PCR and sequence analysis confirmed the replacement of the
relA gene with the spec cassette.
FLP recombinase was used to remove the spec cassette as described
previously (33). PCR and sequence analysis confirmed deletion of relA.
The final mutant was designated 35000HPrelA. Primers P15 and P16
were used to determine if relA affected expression of the downstream dxr
gene using qRT-PCR; deletion of relA did not affect transcription of dxr
(data not shown).
Using these methods, a spoT mutant was not recovered. As has been
observed for other species, a spoT deletion mutant may be lethal in H.
ducreyi due to unopposed ppGpp synthesis by relA (35). Therefore, we
constructed a relA spoT double-deletion mutant by deleting spoT in the
relA mutant exactly as described above, except that primers P17 and P18
were used to amplify the spec cassette and primers P19 and P20 were used
to amplify the spoT coding and flanking regions, resulting in pCH11 (Ta-
ble 1). After allele exchange and excision of the spec cassette, PCR and
sequence analysis confirmed deletion of the spoT gene. The double mu-
tant was designated 35000HPrelAspoT. To determine if deletion of
spoT affected the expression of itsmenB downstream gene, qRT-PCR was
performed using primers P21 and P22; deletion of spoT did not affect
transcription of menB (data not shown).
To complement the relA spoTdeletionmutant, the relA and spoT genes
were expressed under the control of a constitutive chloramphenicol pro-
moter from pACYC184 in the pACYC177 expression vector. Briefly,
the spoT open reading frame (ORF), along with 21 bp of the upstream
region and 22 bp of the downstream region, was amplified using prim-
ers P23 and P24. The relA open reading frame, along with 21 bp of the
upstream region and a 45-bp downstream region, which includes the
native transcription terminators, was amplified using primers P25 and
P26. The chloramphenicol promoter was amplified from pACYC184
using primers P27 and P28. The PCR fragments were combined with
BamHI-digested pACYC177 in a Gibson assembly reaction (36).
Briefly, the three fragments were incubated at 50°C for 1 h in a reaction
mixture (kindly provided by M. Goebl, Indiana University) that con-
tained T5 exonuclease (Epicentre), Phusion Taq (New England Bio-
Labs), and Taq DNA ligase (New England BioLabs). The final con-
struct, designated pCH30, was confirmed by PCR and sequence
analysis and electroporated into H. ducreyi 35000HPrelAspoT to
yield H. ducreyi 35000HPrelAspoT(pCH30). As controls, H. ducreyi
35000HP and 35000HPrelAspoT were also electroporated with
pACYC177, and the resulting strains were designated H. ducreyi
35000HP(pACYC177) and 35000HPrelAspoT(pACYC177), respec-
tively.
Human inoculation experiments. Human inoculation experiments
were conducted according to the guidelines of the U.S. Department of
Health and Human Services and the Institutional Review Board (IRB) of
Indiana University. Healthy adult volunteers (6 females and 4 males; 7
African Americans, 1 Asian, and 2 European Americans; mean age 	
standard deviation, 48 	 9.17 years) over 21 years of age initially
enrolled in the study. All volunteers gave written, informed consent
for participation and HIV serology. Two volunteers were excluded due
to underlying medical conditions, and two withdrew consent prior to
the start of the trial. The procedures for the human inoculation exper-
iments, including calculation of the estimated delivered dose (EDD),
are described in detail elsewhere (17). Papule and pustule formation
rates for parent and mutant inoculation sites were compared using
logistic regression with generalized estimating equations (GEE) as pre-
viously described (37). Ninety-five-percent confidence intervals (95%
CI) for papule and pustule formation rates were calculated using GEE-
based sandwich standard errors.
To ensure that the inocula contained the correct strains and that there
was no cross contamination of samples, colony hybridization was per-
formed on colonies derived from the inocula, surface cultures, and biopsy
specimens. Probes specific for relA, spoT, and dnaE were designed using
primer pair P29 andP30, primer pair P31 andP32, and primer pair P1 and
P2, respectively. A digoxigenin (DIG) DNA labeling kit (Roche Applied
Sciences) was used to label the probes with digoxigenin, and detectionwas
performed using the DIG Easy Hyb protocol from the manufacturer’s
instructions.
(p)ppGpp synthesis assay. For detection of (p)ppGpp synthesis inH.
ducreyi, we modified two published assays (38, 39). Briefly, H. ducreyi
strainswere grown inGCbroth. At different phases of growth, the bacteria
were harvested by centrifugation, washed in phosphate-limited RPMI
medium (US Biological Life Sciences), and suspended (1
 105 cells/ml)
in phosphate-limited RPMI medium. Pilot experiments showed that
there was no reduction in bacterial viability for up to 4 h in thismedia. For
the labeling experiments, the bacteria were suspended in phosphate-lim-
ited RPMI media supplemented with 5% fetal bovine serum (FBS) and
KH2
32PO4 (PerkinElmer) (specific activity, 900 to 1,100 mCi/mmol) at
100 Ci/ml. The bacteria were incubated for 3 h, washed, and incubated
for an additional 15min in phosphate-limited RPMImedium. For extrac-
tion of (p)ppGpp, cells were treated with 40mg/ml lysozyme–10mMTris
HCl (pH 8.0) for 20 min and lysed on ice using 1% SDS (wt/vol) for 20
min. Finally, an equal volume of 13M formic acid was added to the lysate,
which was incubated on ice for 15 min. Cell debris was removed by cen-
trifugation. A sample of the supernatant containing the extracted
(p)ppGpp was spotted onto polyethyleneimine (PEI) cellulose thin-layer
chromatography (TLC) plates (Sigma-Aldrich). (p)ppGpp was separated
in 1.5 M H3PO4 (pH 3.4) buffer and detected using autoradiography.
CTP, ATP, and GTP standards (Sigma-Aldrich) were detected using io-
dine staining.
Phenotypic comparisons. Lipooligosaccharides (LOS) and outer
membrane proteins (OMP) were isolated from H. ducreyi 35000HP,
35000HPrelA, and 35000HPrelAspoT and analyzed as described pre-
viously (40, 41). Bactericidal assays were performed on plate-grown or-
ganisms as described previously (42). To determine the expression levels
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of OmpP2B, DsrA, and the peptidoglycan-associated lipoprotein (PAL),
Western blot analyses were performed using purified outer membranes
and the blots were probedwith antisera ormonoclonal antibodies specific
to each protein. The antisera for OmpP2B (kindly provided by A. Cam-
pagnari, StateUniversity ofNewYork [SUNY]-Buffalo) andDsrA (kindly
provided by C. Elkins, University of North Carolina) and the PALmono-
clonal antibody were described elsewhere (41, 43–45).
To determine if the relA and spoT deletion affected the transcript levels
of specific H. ducreyi genes, total RNA was extracted from mid-log- and
stationary-phase H. ducreyi 35000HP and 35000HPrelAspoT. qRT-
PCR was performed using primer pair P33 and P34 to amplify cpxA,
primer pair P35 and P36 to amplify lspB, primer pair P37 and P38 to
amplify oxyR, primer pair P39 and P40 to amplify sodC, and primer pair
P41 and P42 to amplify dksA.
Macrophage uptake assays. Human peripheral blood mononuclear
cells (PBMCs) were isolated from leukopacks obtained from anonymous
donors from the Central Indiana Regional Blood Center or from blood
obtained from healthy volunteers. Informed consent was obtained in ac-
cordance with an IRB-approved protocol. PBMCswere isolated by Ficoll-
Pacque Plus purification, and CD14 cells were isolated (Miltenyi Bio-
tech). The CD14 cells were differentiated into monocyte-derived
macrophages (MDMs) in X-vivo 15medium (Lonza) supplemented with
1% human AB serum (Invitrogen) for 5 days. The MDMs were harvested
by centrifugation and seeded into 24-well tissue culture plates at 4 
105
cells per well and grown for 24 h. H. ducreyi 35000HP, 35000HPrelA,
and 35000HPrelAspoT were grown to the mid-log and stationary
phases and opsonized in 100% complement-replete normal human se-
rum for 20 min at room temperature. After washes with Hanks’ balanced
salt solution (HBSS) were performed, the MDMs were infected with bac-
teria at a multiplicity of infection (MOI) of 10:1. The plates were centri-
fuged at 1,800 
 g for 5 min to synchronize the infections and were
incubated for 30 min at 35°C in 5% CO2. To kill extracellular bacteria,
gentamicin (100g/ml) was added, and theMDMswere incubated for 30
min and washed with HBSS. TheMDMs were lysed with 0.2% saponin at
room temperature for 10 min, and the lysates were quantitatively cul-
tured. The percentage of bacterial uptake was calculated as the ratio of
bacteria within the lysed MDMs compared to the initial CFU.
Oxidative stress and heat shock assays. Bacteria were treated either
with hydrogen peroxide (H2O2) to mimic extracellular oxidative stress
or with paraquat to mimic intracellular oxidative stress, as described
previously (46). Briefly, H. ducreyi 35000HP, 35000HPrelA, and
35000HPrelAspoT were grown to the mid-log or stationary phase and
exposed to 0.2 mM and 2 mM H2O2 (Sigma-Aldrich) or 0.2 mM and 2
mMparaquat (Sigma-Aldrich)with PBS at 33°C for 1 h and quantitatively
cultured. To determine the effect of deletion of relA and spoTon the ability
to survive heat shock, cells collected from the mid-log and stationary
phases were incubated at 37°C for 1 h in PBS and quantitatively cultured.
Percent survival was calculated as the ratio of recovered bacteria to the
input CFU. An untreated control was utilized as a measure of viability.
Due to growth issues with H. ducreyi strains containing the pACYC177
vector, for complementation assays, H. ducreyi 35000HP(pACYC177),
35000HPrelAspoT(pACYC177), and 35000HPrelAspoT(pCH30)
were grown only to the mid-log phase and harvested, and the assay was
performed as described above.
Statistical analysis. Stress, bactericidal, and macrophage uptake data
were analyzed using a mixed-model analysis of variance (ANOVA) fol-
lowed by Tukey’s honestly significant difference test. RT-PCR and densi-
tometry data were analyzed using a paired t test followed by Tukey’s ad-
justment. An adjusted two-sided P value of 0.05 was considered
statistically significant. The data are expressed as means	 standard devi-
ations. For growth curve analysis, the data were log transformed before
analysis to correct for the large amount of skewness in the distribution.
They were then analyzed using repeated-measurement (mixed-model)
ANOVA followed by pairwise analysis of the 3 strains at each time point.
The tests were adjusted for multiple comparisons using the Tukey
method.
RESULTS
Characterization of the relA and spoT genomic loci. The H. du-
creyi homolog of relA (HD1185) is in the same orientation and 77
bp upstream of the dxr coding region, which is predicted to en-
code a DXP reductoisomerase (Fig. 1A). To examine whether relA
and dxr were in an operon, we conducted RT-PCR on the inter-
genic regions between relA and dxr. Although RT-PCR confirmed
that both the relA and dxr transcripts were present in the cDNA
utilized for analysis (data not shown), the data suggested that relA
had not been cotranscribedwith dxr (Fig. 1B). TheH. ducreyi spoT
homolog (HD1924) is in a putative operon with the gene order
recG¡ rpoZ¡ spoT¡menB (Fig. 1C). The recG, rpoZ, andmenB
genes are predicted to encode an ATP-dependent DNA helicase,
RNApolymerase omega chain, and dihydroxynaphthoic acid syn-
thase, respectively. RT-PCR suggested that spoT is cotranscribed
with rpoZ, menB, and recG (Fig. 1D).
Construction of relA and relA spoT deletionmutants.To un-
derstand the role of (p)ppGpp inH. ducreyi pathogenesis, we con-
structed an unmarked, in-frame relA single-deletion mutant and
an unmarked, in-frame relA spoT double-deletion mutant. PCR
and sequence analysis confirmed that both the relA and spoT genes
were deleted in H. ducreyi 35000HPrelAspoT, with the excep-
tion of the start codon and the last 21 bp of the relA and spoT
ORFs.
H. ducreyi synthesizes (p)ppGpp, and deletion of relA
and spoT results in loss of (p)ppGpp synthesis. To determine
if H. ducreyi synthesizes (p)ppGpp, H. ducreyi 35000HP,
FIG 1 Chromosomal loci containing relA and spoT in H. ducreyi. (A)
Genomic organization of relA locus in H. ducreyi. The small arrows indicate
locations of intergenic primers used for RT-PCR analysis. (B) Agarose gel
electrophoresis of the relA-to-dxr intergenic region amplified by RT-PCR.
Lane 1, RNA sample with reverse transcriptase; lane 2, RNA sample without
reverse transcriptase control; lane 3, genomic DNA control; lane 4, no-tem-
plate control. (C) Genomic organization of spoT locus inH. ducreyi. (D) Aga-
rose gel electrophoresis of products amplified by RT-PCR. The intergenic re-
gions of recG to rpoZ, rpoZ to spoT, and spoT tomenBwere examined. Lanes are
as described for panel B. Products were of the expected sizes: relA to dxr, 515
bp; recG to rpoZ, 541 bp; rpoZ to spoT, 497 bp; spoT to menB, 222 bp.
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35000HPrelA, and 35000HPrelAspoT were grown to the mid-
log, transition, and stationary phases, harvested, and labeled with
KH2
32PO4; (p)ppGpp was detected using autoradiography. This
assay detects de novo (p)ppGpp synthesis only in the absence of
induced stress. (p)ppGpp synthesis was detected in strain
35000HP grown to the mid-log and transition phases; maximal
synthesis was detected in cells harvested from the transition phase
(Fig. 2). Synthesis of (p)ppGpp was detected only variably in
35000HP harvested from the stationary phase (data not shown).
We detected only one species of the molecule and were unable to
distinguish between ppGpp and pppGpp. In both H. ducreyi
35000HPrelA and H. ducreyi 35000HPrelAspoT collected
from all phases of growth, synthesis of (p)ppGpp was not de-
tected. Thus, under these growth conditions, both the relA single
mutant and the relA spoT double mutant had a (p)ppGpp0 phe-
notype.
relA and spoT contribute to H. ducreyi virulence in human
volunteers. To determine if RelA and SpoT contribute to viru-
lence in humans, we inoculated volunteers in four iterations
with H. ducreyi 35000HP and with the 35000HPrelAspoT
mutant. In the first iteration, one volunteer was inoculated at
three sites with an EDD of 157 CFU of H. ducreyi 35000HP and
at three sites with an EDD of 24, 48, and 96 CFU of H. ducreyi
35000HPrelAspoT. In the second iteration, three volunteers
were each inoculated at three sites with an EDD of 74 CFU of H.
ducreyi 35000HP and with the 35000HPrelAspoT mutant at
three sites with EDDs of 33, 66, and 132 CFU. In the third itera-
tion, one volunteer was inoculated with an EDD of 49 CFU of H.
ducreyi 35000HP at three sites and at EDDs of 21, 41, and 81 CFU
of the 35000HPrelAspoTmutant at three sites. In the final iter-
ation, one volunteer was inoculated with an EDD of 81 CFU ofH.
ducreyi 35000HP at three sites and at three sites with EDDs of 35,
71, and 141 of the 35000HPrelAspoTmutant. Overall, papules
formed at 94% (95% CI, 84.5% to 99.9%) of the parent-inocu-
lated sites and at 94% (95% CI, 84.5% to 99.9%) of the mutant-
inoculated sites (P  1.0) (Table 2). After 24 h of infection, the
mean surface areas of the papules were 23.7	 24.4 mm2 at parent
sites and 18.2 	 22.4 mm2 at mutant sites (P  0.36). Pustules
formed at 72.2% (95% CI, 48.3% to 96.2%) of parent sites and
27.8% (95% CI, 0.1% to 56.2%) of mutant sites (P  0.0001).
FIG 2 De novo synthesis of (p)ppGpp inH. ducreyi. Bacteria were labeled with
KH2
32PO4 in phosphate-limited RPMI medium plus 5% FBS. (p)ppGpp was
extracted and detected by polyethylenimine cellulose thin-layer chromatography
and autoradiography. Synthesis of (p)ppGppwas detected in cells harvested from
themid-log and transition phases of growth. Lanes 1,H. ducreyi 35000HP; lanes
2,H. ducreyi 35000HPrelA; lanes 3,H. ducreyi 35000HPrelAspoT. The blot
is representative of three independent experiments.
TABLE 2 Response to inoculation of live H. ducreyi strains
Volunteer (sex)a
Observation
period (days) Strainb Dose (CFU)c
No. of initial
papules
Final papule outcome
No. resolved No. of pustules
433 (F) 7 P 157 3 2 1
M 24–96 3 3 0
436 (F) 8 P 74 3 0 3
M 33–132 3 2 1
437 (F) 7 P 74 3 0 3
M 33–132 2 1 1
438 (M) 7 P 74 3 0 3
M 33–132 3 0 3
439 (M) 7 P 49 3 1 2
M 21–81 3 3 0
440 (M) 9 P 81 2 1 1
M 35–141 3 2 0
a Volunteer 433 was inoculated in the first iteration. Volunteers 436, 437, and 438 were inoculated in the second iteration. Volunteer 440 was inoculated in the third iteration.
Volunteer 439 was inoculated in the fourth iteration. M, male; F, female.
b P, parent H. ducreyi strain 35000HP; M, mutant H. ducreyi strain 35000HPrelAspoT.
c Doses inoculated at 3 sites, except 24–96 (one dose each of 24, 48, and 96 CFU), 33–132 (one dose each of 33, 66, and 132 CFU), 21–81 (one dose each of 21, 41, and 81 CFU),
and 35–141 (one dose each of 35, 71, and 141 CFU).
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Thus, the relA spoT mutant was partially attenuated for pustule
formation in humans.
Three volunteers (436, 437, and 438) developed pustules at
bothmutant and parent sites. For each subject, one parent site and
one mutant site were subjected to a biopsy procedure and the
biopsy specimens were divided in half and semiquantitatively cul-
tured or stained with hematoxylin-eosin and anti-CD3 antibodies
as previously described (47). All samples containedmicropustules
in the epidermis and dermal CD3 cells (data not shown). Histo-
pathologically, the pustules formed at mutant sites were indistin-
guishable from the pustules formed at parent sites.
All colonies recovered from the inocula, surface cultures, and
biopsy specimens were tested for the presence of relA, spoT, and
dnaE sequences by colony hybridization. The dnaE probe hybrid-
ized to all the colonies tested from both parent (n  144) and
mutant (n 140) inocula, while the relA and spoT probes hybrid-
ized only to colonies from the parent inocula. At least one positive
surface culture forH. ducreyiwas obtained during follow-up visits
from 39.9% of the parent inoculation sites and 16.7% of the mu-
tant inoculation sites. The dnaEprobe hybridized to colonies from
both parent-inoculated sites (n  280 colonies) and mutant-in-
oculated sites (n  32 colonies), while the relA and spoT probes
bound only to colonies from the parent sites. All 3 paired biopsy
specimens of mutant and parent pustules yielded H. ducreyi. The
dnaE probe hybridized to all parent (n  108) and mutant (n 
101) colonies obtained from the biopsy specimens, while the relA
and spoT probes hybridized only to colonies obtained from the
parent biopsy specimens. There was no evidence of cross contam-
ination between the inocula and mutant and parent inoculation
sites.
Deletion of relA and spoT affects the growth and survival of
H. ducreyi. To determine the effect of the loss of (p)ppGpp on the
growth and survival ofH. ducreyi, we compared the growth of the
mutant strains to the growth of the parent strain in broth culture.
By quantitative culture, the strain results determined by time in-
teraction analysis were significant (P0.0001), indicating that
the differences between the parent strain and either mutant were
not consistent over time. The growth of each mutant strain was
not different from that of the parent strain from 0 to 16 h (Fig. 3),
but both mutants survived longer than the parent strain in broth
culture from 24 to 36 h (P0.0001), suggesting that the lack of
production of (p)ppGpp enhanced survival in the stationary
phase.
Deletion of relA alters the OMP profile of H. ducreyi. As
required by our clinical protocol, we investigated whether
deletion of relA and spoT affected the expression of outer
membrane components of H. ducreyi. LOS and OMP were
prepared from H. ducreyi 35000HP, 35000HPrelA, and
35000HPrelAspoT harvested from mid-log phase. The
35000HP, 35000HPrelA, and 35000HPrelAspoT strains had
identical LOS profiles (data not shown). Analysis of OMP
showed increased expression of a band that migrates between
40 to 45 kDa in both H. ducreyi 35000HPrelA (data not shown)
and H. ducreyi 35000HPrelAspoT compared to the parent
strain (Fig. 4A). Preliminary tandem mass spectrometry experi-
ments done on the excised band suggested that the overexpressed
protein was OmpP2B, a putative porin previously described inH.
ducreyi (data not shown) (43). Western blot analysis performed
with an OmpP2B-specific antibody confirmed that the relA spoT
mutant expressedmore OmpP2B than the parent strain (Fig. 4B).
By OMP profile analysis, the size of a band that migrates
with the apparent molecular weight of DsrA, the major deter-
minant of serum resistance, seemed to be decreased in both
H. ducreyi 35000HPrelA (data not shown) and H. ducreyi
35000HPrelAspoT relative to strain 35000HP (Fig. 4A). By
Western blotting, the level of expression of DsrA in H. ducreyi
35000HPrelAspoTwas somewhat reduced compared to that in
strain 35000HP (Fig. 4C). We harvested cells from the 3 strains
collected at the mid-log, transition, and stationary phases of
growth; Western blot and densitometry analysis showed that ex-
pression of DsrA was significantly reduced in both the single mu-
tant (P 0.05) and the double mutant (P 0.043) compared to
that in the parent strain in cells collected at mid-log phase but not
in cells collected at the transition or stationary phase (all P values
0.24) (Fig. S1A in the supplemental material and data not shown).
In bactericidal assays using 50% normal human serum,H. ducreyi
35000HPrelAspoTwas as resistant to killing as the parent strain
(see Fig. S1B). Thus, the reduction in DsrA expression in the mu-
tant during the mid-log phase may not be biologically significant.
RelA and SpoT do not contribute to heat stress resistance. In
other organisms, (p)ppGpp induces expression of genes critical
for responses to heat shock such as rpoH (48–50). H. ducreyi
35000HP grows optimally at 33°C (51). To determine if relA
FIG 3 Growth of H. ducreyi (p)ppGpp mutants. (A) Growth of H. ducreyi
35000HP, 35000HPrelA, and 35000HPrelAspoTmeasured by absorbance
at OD660 over 48 h. The OD data are means	 standard deviations (SD) of the
results of 3 independent experiments. (B) Growth of H. ducreyi 35000HP,
35000HPrelA, and 35000HPrelAspoT measured as CFU over 48 h. The
CFU data are geometric means 	 SD of the results of three independent ex-
periments. ****, P 0.0001.
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and spoT had a role in regulating responses to heat shock, we
compared the survival of H. ducreyi 35000HPrelA and
35000HPrelAspoT to that of strain 35000HP after incubation
at 37°C for 1 h. Percent survival rates were not significantly differ-
ent among the strains (data not shown). Thus, RelA and SpoT did
not contribute to H. ducreyi survival following heat shock.
Deletion of relA spoT decreased uptake of mid-log-phase-
grownH. ducreyi by macrophages. During both natural and ex-
perimental infection, H. ducreyi associates with neutrophils and
macrophages but remains extracellular (18, 52). LspB is required
for the secretion of LspA1 and LspA2, which are responsible for
resistance to phagocytosis (53, 54). lspB and lspA2 are cotrans-
cribed; LspB is maximally expressed and LspA1 and LspA2 are
maximally secreted during the stationary phase. To determine the
role of (p)ppGpp in resistance to phagocytosis, we compared rates
of uptake by primary humanmacrophages ofH. ducreyi 35000HP,
35000HPrelA, and 35000HPrelAspoT cells grown to themid-
log and stationary phases. No differences were found for the up-
take of cells harvested at the stationary phase (Fig. 5A). However,
compared to the parent strain, a significant reduction in the up-
take of the relAspoT mutant (P 0.0076) and a trend toward
reduction in the uptake of the relA mutant (P  0.052) were
shown for cells harvested at themid-log phase. Since the uptake of
the mutants was growth phase dependent, we assessed if the mu-
tants had altered transcript levels of lspB relative to the parent. By
qRT-PCR, lspB expression was increased in cells grown to the
mid-log phase for both H. ducreyi 35000HPrelA (2.51 	 0.92,
P  0.027) and 35000HPrelAspoT (2.14 	 0.54, P  0.029)
(Fig. 5B). No differences in lspB expression were found among the
three strains grown to stationary phase (Fig. 5B). Thus, the in-
creased expression of lspB in the mutants grown to the mid-log
phase may explain their reduced uptake by macrophages.
RelA and SpoT are important for resistance to oxidative
stress. (p)ppGpp expression is critical for the survival of bac-
teria exposed to oxidative stress (30, 55, 56). We compared the
survival rates of H. ducreyi 35000HP, 35000HPrelA, and
35000HPrelAspoT after incubation with either hydrogen per-
oxide or paraquat. When mid-log-phase or stationary-phase bac-
teria were incubated with 0.2 mM or 2 mM H2O2, both the relA
and relA spoT mutants survived at significantly lower levels than
the parent strain (Fig. 6A). When bacteria in either the mid-log
phase or stationary phase were incubated with 0.2 mM or 2 mM
paraquat, the relA and relA spoTmutants survived at significantly
lower levels than the parent strain (Fig. 6C). Complementation of
the relA spoTmutant in trans with plasmid pCH30 restored resis-
tance to both 0.2 mM and 2 mMH2O2 (Fig. 6B) and 2 mM para-
quat (Fig. 6D). Therefore, RelA and SpoT contribute toH. ducreyi
survival under oxidative stress conditions.
Given that the relA spoTmutant was more sensitive to oxidative
FIG 4 Outer membrane protein expression by H. ducreyi harvested from the
mid-log phase. (A) Purified outer membranes were analyzed by SDS-PAGE
and Coomassie staining. Arrows indicate protein bands selected for further
analysis. Open arrow, OmpP2B; filled arrow, DsrA. Lane 1, H. ducreyi
35000HP; lane 2, H. ducreyi 35000HPrelAspoT. (B) Western blot analysis
of purified outer membrane proteins of H. ducreyi 35000HP and
35000HPrelAspoT. Lysates were probed with OmpP2B-specific antibody.
(C) Western blot analysis of purified outer membrane proteins of H. ducreyi
35000HP, H. ducreyi 35000HPrelAspoT, and the dsrA mutant, FX517. Ly-
sates were probed with DsrA-specific antibody. PAL monoclonal antibody
(MAb) 3B9 was used to verify equivalent levels of loading. Lanes 1 and 2 are as
described for panel A; lane 3, FX517.
FIG 5 Uptake ofH. ducreyi by humanmacrophages. (A) Percent uptake ofH.
ducreyi 35000HP, 35000HPrelA, and 35000HPrelAspoT by human mac-
rophages. Primary human CD14 cells were differentiated into monocyte-
derived macrophages (MDMs). MDMs were infected with opsonized H. du-
creyi at an MOI of 10:1. After 30 min of incubation, gentamicin was added to
kill extracellular bacteria. Percent uptake was calculated as [(geometric mean
CFU of gentamicin-protected bacteria at 1 h/geometric mean CFU of input
bacteria) 
 100]. Data are means 	 SD of the results determined with five
independent donors. (B) Fold change in the expression of lspB in H. ducreyi
35000HPrelA and 35000HPrelAspoT relative to 35000HP. Expression lev-
els of genes were normalized to dnaE. The data represent the means	 SD of
the results from three independent RNA samples. *, P 0.05; **, P 0.01.
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stress, we investigatedwhether (p)ppGpp regulated the expression of
genes that encode putative oxidative stress-responsive proteins. The
oxyR and sodC genes encode the hydrogen peroxide-inducible gene
activator and periplasmic Cu-Zn superoxide dismutase, respectively.
Compared to the parent strain, transcript levels of both oxyR and
sodCwere unchanged in the 35000HPrelAspoTmutant (data not
shown). Thus, the mechanism of (p)ppGpp-mediated resistance to
oxidative stress is unclear.
Deletion of relA and spoT affects the expression of dksA.
DksA is an important cofactor of (p)ppGpp that helps stabilize the
interaction of (p)ppGpp with RNA polymerase (57). As overex-
pression of dksA has been shown to compensate for the loss of
(p)ppGpp in other bacteria, we sought to determine if loss of
(p)ppGpp affected transcript levels of dksA. qRT-PCR showed
that, compared to the wild-type strain results, dksA was signif-
icantly upregulated in the 35000HPrelAspoT mutant har-
vested from the mid-log phase (4.31 	 0.87, P  0.0025) and
the transition phase (5.33	 2.01, P 0.03) of growth. No differ-
ence in the levels of dksA expression was found between the
35000HPrelAspoT and 35000HP strains grown to the station-
ary phase. Thus, loss of relA and spoTmay be in part compensated
by upregulation of dksA.
DISCUSSION
Many bacterial species sense and respond to nutrient stress by
utilizing the stringent response, which is regulated by (p)ppGpp.
During human infection, H. ducreyi is found in the hostile envi-
ronment of an abscess.WhetherH. ducreyi is nutritionally stressed
in this environment is unknown. Nevertheless, here we showed
that an H. ducreyi (p)ppGpp0 mutant is partially attenuated for
FIG 6 H. ducreyi survival after oxidative stress at the mid-log and stationary phases. (A) Percent survival of H. ducreyi 35000HP, 35000HPrelA, and
35000HPrelAspoT following incubation with 0.2 mM or 2 mM H2O2 for 1 h. (B) Percent survival of mid-log-phase H. ducreyi 35000HP (pACYC177),
35000HPrelAspoT (pACYC177), and the complemented 35000HPrelAspoT strain (pCH30) following incubation with 0.2 mMor 2mMH2O2 for 1 h. (C)
Percent survival of H. ducreyi 35000HP, 35000HPrelA, and 35000HPrelAspoT following 1 h of incubation with 0.2 mM or 2 mM paraquat. (D) Percent
survival of mid-log-phaseH. ducreyi 35000HP (pACYC177), 35000HPrelAspoT (pACYC177), and 35000HPrelAspoT (pCH30) following incubation with
0.2 mM or 2 mM paraquat for 1 h. All percent survival values were calculated as [(geometric mean CFU after treatment/geometric mean before treatment)

100]. The data are means	 SD of the results of four independent experiments. *, P 0.05; **, P 0.01; ***, P 0.001; ****, P 0.0001. NS, not significant.
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virulence in human volunteers, suggesting that (p)ppGppplays an
important role in H. ducreyi pathogenesis.
TheH. ducreyiRelA and SpoT proteins are 59% and 69% iden-
tical to their respective homologs in E. coli. In E. coli, RelA is a
monofunctional enzyme that catalyzes the synthesis of (p)ppGpp;
SpoT is a bifunctional enzyme that primarily catalyzes hydrolysis
of (p)ppGpp and has limited synthetic capabilities (58). We con-
structed a relA single-deletion mutant and a relA spoT double-
deletion mutant in H. ducreyi but were unable to recover a spoT
deletion mutant. In other organisms, expression of a (p)ppGpp
synthase in the absence of a hydrolase leads to growth arrest and
cell death; therefore, for many species, spoT is considered an es-
sential gene (35, 59). In a radiolabeling-based de novo (p)ppGpp
synthesis assay, both the H. ducreyi relA and relA spoT mutants
were unable to synthesize (p)ppGpp. As there is no defined me-
dium available forH. ducreyi, one limitation of our data is that we
did not study (p)ppGpp synthesis in response to nutrient stress,
which is usually used to enhance the synthetase activity of these
enzymes.Given that deletion of relA alonewas sufficient to abolish
the ability of H. ducreyi to synthesize (p)ppGpp and that we were
not able to construct a spoT mutant in the presence of relA, these
data suggest that RelA is likely the primary (p)ppGpp synthetase
and that SpoT is likely the primary (p)ppGpp hydrolase in H.
ducreyi.
Recently, (p)ppGpp was shown to have a role in exponential
growth (60). The H. ducreyi relA spoT mutant grown to the mid-
log phase exhibited several phenotypes different from those of its
parent that were not seen when the mutant was grown to station-
ary phase, including significantly reduced uptake by macro-
phages, increased transcript levels of lspB, increased transcript lev-
els of dksA, reduction in the expression levels of DsrA, and
upregulation in the expression levels of the porinOmpP2B. Given
that many of the phenotypes associated with deletion of relA spoT
were observed in cells grown to themid-log phase but not in those
grown to the stationary phase, these data suggest that (p)ppGpp
likely plays a role in gene regulation during the exponential
growth of H. ducreyi.
SinceH. ducreyi colocalizes withmacrophages and neutrophils
during natural and experimental infection, the organism is likely
exposed to reactive oxygen species from phagocytes (18, 61). In
addition,H. ducreyimay be exposed to oxidative free radicals gen-
erated endogenously duringmetabolism. Both the relA singlemu-
tant and relA spoT double mutant showed increased sensitivity to
H2O2- and paraquat-induced oxidative stress in vitro. Taken to-
gether, these data suggest that the attenuation of the (p)ppGpp0
mutant in humans may be in part due to increased sensitivity of
the (p)ppGpp0 mutant to oxidative stress.
The relA spoT double mutant formed pustules at a rate signif-
icantly lower than the parent in human volunteers and met the
criteria for partial attenuation in themodel (17). SinceOmpP2B is
not required for pustule formation in humans (62), the increased
expression of OmpP2B by the mutant likely had no effect on its
virulence. The increased sensitivity to oxidative stress and the
growth-phase-dependent reduction in the expression of DsrA fa-
vor attenuation of the mutant. However, the growth-phase-de-
pendent upregulation of lspB transcripts, the decreased uptake by
macrophages, and the increased longevity of the mutant in the
stationary phase favor virulence. DksA phenotypically compen-
sates for the loss of (p)ppGpp in a (p)ppGpp0 mutant in E. coli
(63), and the increased transcript levels of dksAmay have partially
compensated for the loss of (p)ppGpp in the mutant and contrib-
uted to the partial attenuation of the mutant in vivo.
Another limitation of our study is that we examined the
(p)ppGpp0 mutant for only a limited number of phenotypes that
are usually associated with the virulence of H. ducreyi in human
volunteers. Given the pleiotropic effects of ppGpp on gene tran-
scription, it is likely that other factors played a role in the attenu-
ation of the (p)ppGpp0mutant.Nevertheless, our findings suggest
an important role for (p)ppGpp in H. ducreyi virulence in hu-
mans. Our findings also highlight the underappreciated roles of
(p)ppGpp in regulating phenotypes associated with exponential
growth. Transcriptome analysis is under way to delineate the
mechanisms underlying (p)ppGpp-mediated functions and its
potential pleiotropic effects inH. ducreyi. Given that upregulation
of dksA may partially compensate for the loss of ppGpp, it will be
interesting to understand the role of DksA inH. ducreyi pathogen-
esis.
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